The Biorepository and Biospecimen Resource (BBR) obtains patient-informed consent to procure malignant and normal tissues from solid tumors and matching peripheral blood products for distribution to The Ohio State University Comprehensive Cancer Center members.
Not only does the BBR maintain the central tissues biorepository and provide quality control of the research specimens through direct interaction with pathologists, the staff also assists researchers with tissue procurement to foster hypothesis-driven cancer research.
The BBR is part of The Human Tissue Resource Network, a large OSU biospecimen processing and banking operation. The network includes: the NCI-funded Cooperative Human Tissue Network, the NCI-funded Cancer and Leukemia Group B Pathology Coordinating Office and specimen banks, the NCI-funded AIDS and Cancer Specimen Resource, the Tissue Archive Services, and the Pathology Core Facility.
Operating according to national and international best-practices procedures (including those of a Biorepository Oversight Committee and Biospecimen Use Committee comprising experts from the various disease groups), the BBR maximizes the value of and access to annotated biospecimens, promoting both basic and translational research.
Director: Scott Scrape, MD